244 related articles for article (PubMed ID: 19824452)
21. Estimating the potential impact of using intravitreal angiostatic agents for wet macular degeneration on service capacity in a large retinal referral centre.
Cheung CM; Peh KK; Yang Y
Eye (Lond); 2007 Aug; 21(8):1121-2. PubMed ID: 17525768
[No Abstract] [Full Text] [Related]
22. Reproducibility of gradings of retinal photographs in eyes with subfoveal choroidal neovascularization and age-related macular degeneration in the macular photocoagulation study.
Jefferys JL; Alexander J; Hiner CJ; Javornik NB; Smith RE; Bressler NM; Hawkins BS
Ophthalmic Epidemiol; 2008; 15(3):191-201. PubMed ID: 18569815
[TBL] [Abstract][Full Text] [Related]
23. Agreement among Canadian retina specialists in the determination of treatment eligibility for photodynamic therapy in age-related macular degeneration.
Muni RH; Altaweel M; Tennant M; Weaver B; Kertes PJ
Retina; 2008; 28(10):1421-6. PubMed ID: 18667952
[TBL] [Abstract][Full Text] [Related]
24. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts.
Noël A; Jost M; Lambert V; Lecomte J; Rakic JM
Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433
[TBL] [Abstract][Full Text] [Related]
25. Pathology beyond neovascularization: new targets in age-related macular degeneration.
Heier JS
Retina; 2009 Jun; 29(6 Suppl):S39-41. PubMed ID: 19553799
[TBL] [Abstract][Full Text] [Related]
26. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
[TBL] [Abstract][Full Text] [Related]
27. Monitoring retinal function during transpupillary thermotherapy for occult choroidal neovascularization in age-related macular degeneration.
Falsini B; Focosi F; Molle F; Manganelli C; Iarossi G; Fadda A; Dorin G; Mainster MA
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2133-40. PubMed ID: 12714653
[TBL] [Abstract][Full Text] [Related]
28. [Multifocal electroretinogram and age-related macular degeneration].
Catalá-Mora J; Castany-Aregall M; Berniell-Trota JA; Arias-Barquet L; Roca-Linares G; Jürgens-Mestre I
Arch Soc Esp Oftalmol; 2005 Jul; 80(7):395-404. PubMed ID: 16059816
[TBL] [Abstract][Full Text] [Related]
29. Rationale for combination therapy in age-related macular degeneration.
Spaide RF
Retina; 2009 Jun; 29(6 Suppl):S5-7. PubMed ID: 19553803
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy for age-related macular degeneration.
Patel S
Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
[TBL] [Abstract][Full Text] [Related]
31. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Ciulla TA; Rosenfeld PJ
Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
Tuñón J; Ruiz-Moreno JM; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; Egido J
Surv Ophthalmol; 2009; 54(3):339-48. PubMed ID: 19422962
[TBL] [Abstract][Full Text] [Related]
33. Opportunities and challenges in the development of combination therapy for the treatment of retinal diseases.
Hohman TC
Retina; 2009 Jun; 29(6 Suppl):S51-3. PubMed ID: 19553804
[TBL] [Abstract][Full Text] [Related]
34. [Different indications of photodynamic therapy in ophthalmology].
Lang GE; Mennel S; Spital G; Wachtlin J; Jurklies B; Heimann H; Damato B; Meyer CH
Klin Monbl Augenheilkd; 2009 Sep; 226(9):725-39. PubMed ID: 19603375
[TBL] [Abstract][Full Text] [Related]
35. Age-related macular degeneration.
Brucker AJ
Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy using the small interfering RNA bevasiranib.
Singerman L
Retina; 2009 Jun; 29(6 Suppl):S49-50. PubMed ID: 19553802
[TBL] [Abstract][Full Text] [Related]
37. VEGF and age-related macular degeneration.
McKay GJ; Silvestri G; Orr N; Chakravarthy U; Hughes AE
Ophthalmology; 2009 Jun; 116(6):1227.e1-3. PubMed ID: 19486801
[No Abstract] [Full Text] [Related]
38. Preclinical efficacy of anecortave acetate.
Clark AF
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S41-8. PubMed ID: 17240256
[TBL] [Abstract][Full Text] [Related]
39. The electroretinogram: a useful tool for evaluating age-related macular disease?
Berrow EJ; Bartlett HE; Eperjesi F; Gibson JM
Doc Ophthalmol; 2010 Aug; 121(1):51-62. PubMed ID: 20232109
[TBL] [Abstract][Full Text] [Related]
40. New perspectives on the treatment of age-related macular degeneration.
Mones J
Drugs Today (Barc); 2005 Nov; 41(11):701. PubMed ID: 16395410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
